Fair Value Calculator Fair Value Calculator
EN DE

Röko AB (ROKO-B) Fair Value & Analysis

Financial Services · SE · Market cap 28.8B SEK

RA Röko AB ROKO-B · ST
Pricekr 1,856
Fair Valuekr 877.67
Upside-52.7%
Quality56/100
Watch Röko AB for free, get notified when fair value or trend changes. Watch for free
Evidence: High Range kr 658.25 – kr 1,097 📤 Share as image

Fair value as of: Jul 16, 2026

From 24 valuation models · updated 5 days ago

Share price −3.0% over the past month.

Price vs Fair Value (12 months)

kr 3,000 kr 1,453 Fair Value kr 877.67 Jul 2025 Jul 2026

12‑month range kr 1,453 – kr 3,000 · fair‑value band kr 658.25 – kr 1,097 · the kr 1,856 price screens above the kr 877.67 fair value. As of Jul 16, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Röko AB (ROKO-B) currently trades at kr 1,856, while our model-based Fair Value estimate is kr 877.67, implying the stock looks roughly 52.7% overvalued today. We read business quality at 56/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Röko AB generated revenue of 6.6B SEK at a net margin of 11.4%. Revenue grew 9.3% year over year. It earns a return on equity of 13.5%. Net debt stands at 1.0B SEK. Fundamentals as of Jul 16, 2026

Our scenario range runs from kr 658.25 (bear case) to kr 1,097 (bull case); at kr 1,856, the current price sits above that range. The share trades about 38% below its 52-week high and 33% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside, at -53%, ROKO-B screens richer than that median.

Key figures & financial health

Revenue (TTM) 6.6B SEK
Revenue growth (YoY) +9.3%
Net margin 11.4%
Return on equity 13.5%
Free cash flow 1.0B SEK FY2025
P/E ratio 38.2
More key figures
Operating margin 18.2%
EPS (TTM) kr 51.67
EPS growth (YoY) +0.8%
Net debt 1.0B SEK FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.

About the company

Röko AB (publ) is a private equity firm specializing in lower middle market, small- and medium-sized businesses. The firm prefers to invest in B2B and B2C markets. The firm typically invests in European region. It typically invests in companies with EBITDA between EUR 2 million ($2.31 million) and EUR 15 million ($17.44 million), along with a margin of at least 15% and EBITDA (A) between $3 million and $15 million and revenue between $15 million and $150 million. The firm only seeks minority stakes. Roko AB (publ) was founded in 2019 and is based in Stockholm, Sweden.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Röko AB reported revenue of kr 6.5B in FY2025 versus kr 2.1B in FY2021, a compound +32.7%/yr. Reported net income was kr 755M in FY2025, compounding +36.6%/yr from FY2021.

Revenue +32.7%/yr
FY21 kr 2.1B
FY22 kr 4.3B
FY23 kr 5.6B
FY24 kr 6.2B
FY25 kr 6.5B
Net income +36.6%/yr
FY21 kr 217M
FY22 kr 386M
FY23 kr 541M
FY24 kr 702M
FY25 kr 755M

Is ROKO-B fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Röko AB Fair Value". https://www.fairvalue-calculator.com/stock/ROKO-B

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $4.20 $6.41 +53%
The Schiehallion Fund Limited MNTN $0.0214 $0.0400 +87%
BlackRock, Inc UU2 €923.80 €569.37 -38%
Blackstone Inc BX $123.26 $52.88 -57%
BH Macro Limited BHMU $0.0442 $0.0900 +104%
Investor AB INVEB kr 388.65 kr 1,430 +268%
BioPharma Credit PLC BPCR $0.0095 $0.0200 +111%
Brookfield Corporation BN $44.13 $11.09 -75%
KKR & Co KKR $96.90 $61.30 -37%
Brookfield Asset Management Ltd BAM C$66.82 C$34.17 -49%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Röko AB (ROKO-B) undervalued?
As of Jul 16, 2026, our model estimates a fair value of kr 877.67 versus a price of kr 1,856, about −53% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ROKO-B?
Our model-based fair value for Röko AB is kr 877.67 (as of Jul 16, 2026), built from audited fundamentals. The current price is kr 1,856.
What is the quality score of ROKO-B?
Röko AB has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Röko AB (ROKO-B)?
Röko AB reported trailing-twelve-month revenue of about 6.6B SEK (latest available figure, as of Jul 16, 2026).
What is the net profit margin of ROKO-B?
The net profit margin of Röko AB is about 11.4%, meaning it keeps roughly 11.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Röko AB analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.